Efficacy News and Research

RSS

Results of high-impact clinical trials could improve kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2016, November 15-20 at McCormick Place in Chicago, IL.

21 Nov 2016

New mouse model by FDA's scientists provides platform for improving understanding of Zika virus pathology

A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines and therapeutics.

17 Nov 2016

Getting drugs to bugs in NTM lung infections: an interview with Dr Jakko van Ingen

The first thing that is important to stress is that this is an area that we actually know very little about. What we generally think, rather than know, is that NTM has a lot in common with pulmonary tuberculosis.

17 Nov 2016

Arthritis drug induces response and remission in patients with Crohn's disease, study finds

Researchers at University of California San Diego School of Medicine have shown that ustekinumab, a human antibody used to treat arthritis, significantly induces response and remission in patients with moderate to severe Crohn's disease.

17 Nov 2016

NYU Langone-led study to examine longer-term use of suppressive antiviral medication to reduce shingles

NYU Langone Medical Center will lead a five-year, 60-center clinical trial to evaluate new treatment protocols for herpes zoster ophthalmicus (HZO), a form of shingles that can seriously and permanently affect the eye.

17 Nov 2016

Phage therapy may be solution to treating antibiotic-resistant bacterial infections

Phage therapy may be a solution to treating infections caused by antibiotic-resistant bacteria. Since 2013, researchers at the University of Helsinki in Finland have collected bacteriophages to combat antibiotic-resistant bacterial strains, and hope to start clinical phage therapy trials in the near future.

16 Nov 2016

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Amgen and Allergan plc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ABP 215, a biosimilar candidate to Avastin (bevacizumab).

16 Nov 2016

New Stepped Care Model for Pain Management holds potential to improve chronic pain care

In the United States, the management of chronic pain in primary care has become overwhelming for primary care providers (PCPs) and ineffectual for patients.

16 Nov 2016

Research findings suggest efficacy of conventional flu vaccines can be improved

A team of engineers and scientists at The University of Texas at Austin is reporting new findings on how the influenza vaccine produces antibodies that protect against disease, research that suggests that the conventional flu vaccine can be improved.

15 Nov 2016

Experts to examine impact of live music on health and morbidity in children with learning disabilities

Experts in the fields of music, education, neurology, psychiatry and psychology will gather at a conference at the Royal Society of Medicine in London on Monday 28 November to examine the current evidence for the value and impact of music interventions, especially live music, on health and morbidity in children with learning disabilities.

15 Nov 2016

New European study emphasizes need to enhance standard of haemophilia care in real life

Swedish Orphan Biovitrum AB (publ) announces the results from a new European study that assessed the efficacy of haemophilia care in real life.

14 Nov 2016

Study to test efficacy of computerized cognitive training for improving memory of heart failure patients

The National Institutes of Health has awarded a $2.5 million grant to an IU School of Nursing researcher for a study that will examine whether computerized cognitive training exercises can improve memory and quality of life for heart failure patients.

11 Nov 2016

New discovery may lead to better treatment options for pancreatic cancer patients

Pancreatic cancer, the third leading cause of cancer-related deaths, is projected to be the second by the year 2030, according to a study in the journal of Cancer Research.

11 Nov 2016

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

Compugen Ltd., a leading predictive drug discovery company, today presented new data for its preclinical CGEN-15029 program demonstrating the potential for the development of new cancer immunotherapy treatments for solid tumors, including the potential for drug combination with current immune checkpoint blockers.

11 Nov 2016

Researchers start enrolling patients for Phase II gene therapy trial for choroideremia

Following on from a successful world’s first Phase I gene therapy trial for choroideremia, Professor Robert MacLaren and his team at Oxford University and the Oxford Eye Hospital at the John Radcliffe Hospital have started a Phase II trial enrolling 30 patients.

11 Nov 2016

New research shows how synthetic DNA vaccine approach protects against Zika virus infection

As the global spread of the Zika virus continues, efforts are underway to halt the disease's transmission.

10 Nov 2016

Researchers lay foundation for improved TB treatment by targeting new enzyme

Researchers at Johns Hopkins report they have laid the foundation to develop novel antibiotics that work against incurable, antibiotic-resistant bacteria like tuberculosis by targeting an enzyme essential to the production and integrity of bacterial cell walls.

10 Nov 2016

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

Allergan plc, a leading global pharmaceutical company, today announced the availability of TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1mg/20mcg, the first and only oral contraceptive in a softgel capsule for the prevention of pregnancy

10 Nov 2016

Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

A study led by researchers at Beth Israel Deaconess Medical Center, in collaboration with scientists at Walter Reed Army Institute of Research, Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson and Gilead Sciences, Inc., has demonstrated that combining an experimental vaccine with an innate immune stimulant may help lead to viral remission in people living with HIV.

9 Nov 2016

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

A Ludwig Cancer Research study shows that an experimental drug currently in clinical trials can reverse the effects of troublesome cells that prevent the body's immune system from attacking tumors.

9 Nov 2016

Efficacy News and Research

Results of high-impact clinical trials could improve kidney-related medical care

New mouse model by FDA's scientists provides platform for improving understanding of Zika virus pathology

Getting drugs to bugs in NTM lung infections: an interview with Dr Jakko van Ingen

Arthritis drug induces response and remission in patients with Crohn's disease, study finds

NYU Langone-led study to examine longer-term use of suppressive antiviral medication to reduce shingles

Phage therapy may be solution to treating antibiotic-resistant bacterial infections

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

New Stepped Care Model for Pain Management holds potential to improve chronic pain care

Research findings suggest efficacy of conventional flu vaccines can be improved

Experts to examine impact of live music on health and morbidity in children with learning disabilities

New European study emphasizes need to enhance standard of haemophilia care in real life

Study to test efficacy of computerized cognitive training for improving memory of heart failure patients

New discovery may lead to better treatment options for pancreatic cancer patients

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

Researchers start enrolling patients for Phase II gene therapy trial for choroideremia

New research shows how synthetic DNA vaccine approach protects against Zika virus infection

Researchers lay foundation for improved TB treatment by targeting new enzyme

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News